{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T01:41:17Z","timestamp":1769391677072,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.vaccine.2018.08.063","type":"journal-article","created":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T12:38:23Z","timestamp":1536928703000},"page":"6314-6324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Potential for HPV vaccination and primary HPV screening to reduce cervical cancer disparities: Example from New Zealand"],"prefix":"10.1016","volume":"36","author":[{"given":"Megan A.","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie-Bin","family":"Lew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Canfell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.08.063_b0005","unstructured":"National Screening Unit. Guidelines for Cervical Screening in New Zealand: Incorporating the management of women with abnormal cervical smears. Wellington: National Screening Unit, Ministry of Health; 2008."},{"key":"10.1016\/j.vaccine.2018.08.063_b0010","unstructured":"Stats NZ. Ethnic group (total responses), for the census usually resident population count, 2001, 2006, and 2013 Censuses. Data extracted from NZ.Stat [access date 30th January 2018]. Available from: <http:\/\/nzdotstat.stats.govt.nz\/wbos\/Index.aspx?DataSetCode=TABLECODE8021#>."},{"key":"10.1016\/j.vaccine.2018.08.063_b0015","unstructured":"Blakely T, Shaw C, Atkinson J, Tobias M, Bastiampillai N, Sloane K, et al. Trends in cancer incidence by ethnic and socioeconomic group, New Zealand 1981\u20132004 Wellington: University of Otago and the Ministry of Health. Available from: http:\/\/www.health.govt.nz\/publication\/trends-cancer-incidence-ethnic-and-socioeconomic-group-new-zealand-1981-2004."},{"issue":"2","key":"10.1016\/j.vaccine.2018.08.063_b0020","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1753-6405.2010.00506.x","article-title":"Improving survival disparities in cervical cancer between Maori and non-Maori women in New Zealand: a national retrospective cohort study","volume":"34","author":"McLeod","year":"2010","journal-title":"Aust N Z J Public Health"},{"issue":"12","key":"10.1016\/j.vaccine.2018.08.063_b0025","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s10552-017-0967-y","article-title":"Impact of the national cervical screening programme in New Zealand by age: analysis of cervical cancer trends 1985\u20132013 in all women and in M\u0101ori women","volume":"28","author":"Smith","year":"2017","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.vaccine.2018.08.063_b0030","unstructured":"Smith M, Rumlee L, Canfell K. National Cervical Screening Programme Annual Report 2014. Wellington; 2017 Available from: <https:\/\/www.nsu.govt.nz\/system\/files\/page\/ncsp-annual-report-2014-jul17.pdf>."},{"key":"10.1016\/j.vaccine.2018.08.063_b0035","unstructured":"Smith M, Rumlee L, Canfell K. National cervical screening programme monitoring report number 45 (1 January\u201330 June 2016). Wellington; 2017 Available from: <https:\/\/www.nsu.govt.nz\/system\/files\/page\/ncsp-monitoring-report-45-jul17.pdf>."},{"key":"10.1016\/j.vaccine.2018.08.063_b0040","unstructured":"Ministry of Health. National Immunisation Schedule Changes: HPV Immunisation Programme Fact Sheet 2 (Nov 2016)2016 [access date 8 February 2017]. Available from: <http:\/\/www.health.govt.nz\/system\/files\/documents\/pages\/hpv_fact_sheet_v2.pdf>."},{"key":"10.1016\/j.vaccine.2018.08.063_b0045","unstructured":"Ministry of Health. HPV Immunisation Coverage December 2016 [access date 10 March 2017]. Available from: http:\/\/www.health.govt.nz\/system\/files\/documents\/pages\/hpv_-selected_cohorts_-all_dhbs_-31_dec_2016_final_for_web.xls."},{"key":"10.1016\/j.vaccine.2018.08.063_b0050","unstructured":"National Screening Unit. Primary HPV Screening Wellington: Ministry of Health; [updated 9 Mar 2016; access date 6 June 2016]. Available from: https:\/\/www.nsu.govt.nz\/health-professionals\/national-cervical-screening-programme\/primary-hpv-screening."},{"issue":"9916","key":"10.1016\/j.vaccine.2018.08.063_b0055","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S0140-6736(13)62218-7","article-title":"Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials","volume":"383","author":"Ronco","year":"2014","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.vaccine.2018.08.063_b0060","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju153","article-title":"Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test","volume":"106","author":"Gage","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.vaccine.2018.08.063_b0065","doi-asserted-by":"crossref","first-page":"e0151619","DOI":"10.1371\/journal.pone.0151619","article-title":"Effectiveness modelling and economic evaluation of primary HPV screening for cervical cancer prevention in New Zealand","volume":"11","author":"Lew","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2018.08.063_b0070","unstructured":"National Screening Unit. National Screening Unit Strategic Plan 2010 to 2015 Auckland: National Screening Unit. Available from: https:\/\/www.nsu.govt.nz\/system\/files\/page\/nsu_strategic_plan_2010-2015.pdf."},{"issue":"12","key":"10.1016\/j.vaccine.2018.08.063_b0075","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1002\/ijc.30392","article-title":"Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries","volume":"139","author":"Simms","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2018.08.063_b0080","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S2468-2667(17)30007-5","article-title":"Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program","volume":"2","author":"Lew","year":"2017","journal-title":"Lancet Public Health"},{"issue":"1","key":"10.1016\/j.vaccine.2018.08.063_b0085","doi-asserted-by":"crossref","first-page":"e0163509","DOI":"10.1371\/journal.pone.0163509","article-title":"Optimal management strategies for primary HPV testing for cervical screening: cost-effectiveness evaluation for the national cervical screening program in Australia","volume":"12","author":"Simms","year":"2017","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.vaccine.2018.08.063_b0090","doi-asserted-by":"crossref","first-page":"194e119e9","DOI":"10.5694\/mja15.00912","article-title":"Impact of HPV sample self-collection for underscreened women in the renewed Cervical Screening Program","volume":"204","author":"Smith","year":"2016","journal-title":"Med J Aust"},{"issue":"2","key":"10.1016\/j.vaccine.2018.08.063_b0095","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1016\/S2468-2667(16)30019-6","article-title":"Cost-effectiveness of the next generation nonavalent human papillomavirus vaccine in the context of primary human papillomavirus screening in Australia: a comparative modelling analysis","volume":"1","author":"Simms","year":"2016","journal-title":"Lancet Public Health"},{"issue":"48","key":"10.1016\/j.vaccine.2018.08.063_b0100","doi-asserted-by":"crossref","first-page":"9112","DOI":"10.1016\/j.vaccine.2011.02.091","article-title":"The predicted impact of HPV vaccination on male infections and male HPV-related cancers in Australia","volume":"29","author":"Smith","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.063_b0105","unstructured":"Medical Services Advisory Committee. Human Papillomavirus triage test for women with possible or definite low-grade squamous intraepithelial lesions. MSAC reference 39, Assessment report. Canberra: Australian Government Department of Health; 2009 Available from: http:\/\/www.msac.gov.au\/internet\/msac\/publishing.nsf\/Content\/8FD1D98FE64C8A2FCA2575AD0082FD8F\/$File\/39_MSAC_Assessment_Report.pdf."},{"issue":"23","key":"10.1016\/j.vaccine.2018.08.063_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18230","article-title":"The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds","volume":"18","author":"Kitchener","year":"2014","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.vaccine.2018.08.063_b0115","doi-asserted-by":"crossref","first-page":"e7086","DOI":"10.1136\/bmj.e7086","article-title":"Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel sites study","volume":"345","author":"Legood","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2018.08.063_b0120","unstructured":"Smith M, Walker R, Canfell K. National Cervical Screening Programme Monitoring Report Number 41 (1 January \u2013 30 June 2014). Wellington; 2015 Available from: https:\/\/www.nsu.govt.nz\/system\/files\/page\/monitoringreport41_final.pdf."},{"key":"10.1016\/j.vaccine.2018.08.063_b0125","unstructured":"Smith M, Walker R, Simms K, Canfell K. National Cervical Screening Programme Annual Report 2012. Wellington; 2014 Available from: https:\/\/www.nsu.govt.nz\/system\/files\/page\/annual_report_2012.pdf."},{"issue":"4","key":"10.1016\/j.vaccine.2018.08.063_b0130","first-page":"228","article-title":"Prevalence of genital human papillomavirus infection in Wellington women","volume":"68","author":"Meekin","year":"1992","journal-title":"GenitourinMed"},{"key":"10.1016\/j.vaccine.2018.08.063_b0135","unstructured":"Ministry of Health. Annual update of key results 2015\/16: New Zealand Health Survey Wellington [access date 28th August 2017]. Available from: http:\/\/www.health.govt.nz\/publication\/annual-update-key-results-2015-16-new-zealand-health-survey."},{"key":"10.1016\/j.vaccine.2018.08.063_b0140","unstructured":"International Agency for Research on Cancer. IARC Monographs on the evaluation of carcinogenic risk to humans Volume 100E: Personal habits and indoor combustions Lyon; 2012 Available from: https:\/\/monographs.iarc.fr\/ENG\/Monographs\/vol100E\/mono100E-6.pdf."},{"issue":"6","key":"10.1016\/j.vaccine.2018.08.063_b0145","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/ijc.21493","article-title":"Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies","volume":"118","year":"2006","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.vaccine.2018.08.063_b0150","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1023\/B:CACO.0000003811.98261.3e","article-title":"Smoking and cervical cancer: pooled analysis of the IARC multi-centric case\u2013control study","volume":"14","author":"Plummer","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.vaccine.2018.08.063_b0155","doi-asserted-by":"crossref","first-page":"847684","DOI":"10.5402\/2011\/847684","article-title":"Smoking and cervical cancer","volume":"2011","author":"Fonseca-Moutinho","year":"2011","journal-title":"ISRN Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2018.08.063_b0160","unstructured":"Ministry of Health. National Cervical Screening Programme policies and standards: section 3: invitation, recall and regional coordination services Wellington: Ministry of Health; [updated July 2014]. Available from: https:\/\/www.nsu.govt.nz\/system\/files\/page\/ncsp_standards_3.pdf."},{"key":"10.1016\/j.vaccine.2018.08.063_b0165","unstructured":"Lewis H. Cervical screening in New Zealand: a brief statistical review of the first decade. Wellington, New Zealand: Ministry of Health; 2005."},{"key":"10.1016\/j.vaccine.2018.08.063_b0170","unstructured":"Blakely T, Costilla R, Soeberg M. Cancer excess mortality rates over 2006-2026 for ABC-CBA. Burden of Disease Epidemiology, Equity and Cost-effectiveness Programme (BODE3) technical report number 10. Wellington: University of Otago; 2012 Available from: http:\/\/www.otago.ac.nz\/wellington\/otago032865.pdf."},{"key":"10.1016\/j.vaccine.2018.08.063_b0175","unstructured":"Ministry of Health. HPV immunisation programme Wellington: Ministry of Health; [updated 27 June 2014; access date 17 February]. Available from: http:\/\/www.health.govt.nz\/our-work\/preventative-health-wellness\/immunisation\/hpv-immunisation-programme."},{"key":"10.1016\/j.vaccine.2018.08.063_b0180","unstructured":"Smith L, Grigg M, Davies L, Reilly J, Laukau S. HPV Immunisation programme implementation evaluation volume 1: final report. Wellington: Litmus, 2013 Available from: http:\/\/www.health.govt.nz\/system\/files\/documents\/publications\/hpv-immunisation-programme-evaluation-v2.pdf."},{"key":"10.1016\/j.vaccine.2018.08.063_b0185","unstructured":"Stats NZ. InfoShare [access date 21 September 2015]. Available from: http:\/\/www.stats.govt.nz\/infoshare\/."},{"key":"10.1016\/j.vaccine.2018.08.063_b0190","unstructured":"National HPV Vaccination Program Register. HPV Vacination Coverage Data [access date 2 November 2016]. Available from: http:\/\/www.hpvregister.org.au\/research\/coverage-data."},{"key":"10.1016\/j.vaccine.2018.08.063_b0195","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pvr.2016.10.001","article-title":"Factors affecting HPV vaccine acceptance in west Austria: Do we need to revise the current immunization scheme?","volume":"2","author":"Borena","year":"2016","journal-title":"Papillomavirus Res"},{"issue":"15","key":"10.1016\/j.vaccine.2018.08.063_b0200","first-page":"1786","article-title":"Human papillomavirus vaccine uptake in boys and girls in a school-based vaccine delivery program in Prince Edward Island,","volume":"33","author":"McClure","year":"2015","journal-title":"CanadaVaccine"},{"issue":"42","key":"10.1016\/j.vaccine.2018.08.063_b0205","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.1016\/j.vaccine.2017.07.079","article-title":"Canadian school-based HPV vaccine programs and policy considerations","volume":"35","author":"Shapiro","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.08.063_b0210","unstructured":"Smith M, Yap S, Canfell K. National cervical screening programme monitoring report number 44 (1 July\u201331 December 2015). Wellington: Ministry of Health; 2017 Available from: https:\/\/www.nsu.govt.nz\/system\/files\/page\/ncsp-monitoring-44.pdf."},{"issue":"1","key":"10.1016\/j.vaccine.2018.08.063_b0215","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1186\/s12885-016-2781-4","article-title":"Ethnic inequalities in cancer incidence and mortality: census-linked cohort studies with 87 million years of person-time follow-up","volume":"16","author":"Teng","year":"2016","journal-title":"BMC Cancer"},{"issue":"22","key":"10.1016\/j.vaccine.2018.08.063_b0220","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1016\/j.vaccine.2014.02.071","article-title":"Cost-effectiveness and equity impacts of three HPV vaccination programmes for school-aged girls in New Zealand","volume":"32","author":"Blakely","year":"2014","journal-title":"Vaccine"},{"issue":"42","key":"10.1016\/j.vaccine.2018.08.063_b0225","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1016\/j.vaccine.2013.07.073","article-title":"Quantifying the impact of dissimilar HPV vaccination uptake among Manitoban school girls by ethnicity using a transmission dynamic model","volume":"31","author":"Shafer","year":"2013","journal-title":"Vaccine"},{"issue":"13","key":"10.1016\/j.vaccine.2018.08.063_b0230","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1002\/cncr.30007","article-title":"Racial and ethnic disparities in human papillomavirus-associated cancer burden with first-generation and second-generation human papillomavirus vaccines","volume":"122","author":"Burger","year":"2016","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.vaccine.2018.08.063_b0235","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/S2468-2667(17)30238-4","article-title":"Effect of HPV vaccination and cervical cancer screening in England by ethnicity: a modelling study","volume":"3","author":"Johnson","year":"2018","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.vaccine.2018.08.063_b0240","unstructured":"National Screening Unit. Providers for breast and cervical screening support services [updated 1st August; access date 13th November 2017]. Available from: https:\/\/www.nsu.govt.nz\/news\/providers-breast-and-cervical-screening-support-services."},{"key":"10.1016\/j.vaccine.2018.08.063_b0245","unstructured":"National Screening Unit. Screening Matters: December 2016. HPV self-sampling trials. [access date 2nd June 2017]. Available from: https:\/\/www.nsu.govt.nz\/news\/screening-matters-issue-57-december-2016\/hpv-self-sampling-trials."},{"issue":"2","key":"10.1016\/j.vaccine.2018.08.063_b0250","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw216","article-title":"Optimal cervical cancer screening in women vaccinated against human papillomavirus","volume":"109","author":"Kim","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.vaccine.2018.08.063_b0255","article-title":"What cervical screening is appropriate for women who have been vaccinated against high risk HPV? a simulation study","author":"Landy","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2018.08.063_b0260","unstructured":"National Screening Unit. Updated Guidelines for Cervical Screening in New Zealand: Consultation document Wellington [updated 25 November 2016; access date 2 February 2017]. Available from: https:\/\/www.nsu.govt.nz\/health-professionals\/national-cervical-screening-programme\/cervical-screening-guidelines\/updated."},{"key":"10.1016\/j.vaccine.2018.08.063_b0265","series-title":"Age standardization of rates: A new WHO standard","author":"Ahmad","year":"2001"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18312027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18312027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T21:56:40Z","timestamp":1604959000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18312027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":53,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0264410X18312027"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.063","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential for HPV vaccination and primary HPV screening to reduce cervical cancer disparities: Example from New Zealand","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.08.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}